Indication-based Coverage

Indication-Based Coverage is a coverage exclusion framework that restricts reimbursement or formulary inclusion of pharmaceuticals based on their approved clinical indications, thereby differentiating medications by therapeutic use rather than chemical class or generic availability.

6

Publications

174

Citations

29

Authors

16

Institutions

Publications per year

2017–2026

3

Publications

6

Authors

29

  1. PH
    Pentti Huovinen

    University of Turku, Finland

    1 publications · 30 citations

    1

    h-index

  2. CW
    Colby Wilkinson

    Tufts Medical Center, United States

    1 publications · 64 citations

    1

    h-index

  3. KL
    Karen Lasch

    Takeda (United States), United States

    1 publications · 14 citations

    1

    h-index

  4. KT
    Katariina Thomson

    University of Helsinki, Finland

    1 publications · 36 citations

    1

    h-index

  5. JS
    Jennifer S. Graff

    National Health Council, United States

    1 publications · 64 citations

    1

    h-index

1–5 of 29

Venues

  1. Health Affairs

    1 publications · 64 citations

    1

    h-index

  2. Scandinavian Journal of Primary Health Care

    1 publications · 30 citations

    1

    h-index

  3. BMC Veterinary Research

    1 publications · 36 citations

    1

    h-index

  4. European Spine Journal

    1 publications · 11 citations

    1

    h-index

  5. Digestive Diseases and Sciences

    1 publications · 14 citations

    1

    h-index

1–5